Cynapsus Announces Publication of Data for the Treatment of OFF Episodes in Patients with PD


(August 16, 2016) - Cynapsus Therapeutics Inc. announced that data from its CTH-105 Phase 2 trial of APL-130277 for the treatment of OFF episodes in patients with Parkinson’s disease was published in the peer-reviewed journal Movement Disorders. Read more…

Click for a printer friendly version

Back to top